Recent advances in the role of the Hippo pathway in head and neck cancer have provided evidence that genetic alterations of PIK3CA or functional loss of FAT1 (FAT atypical cadherin 1) can result in YAP activation [22]. This evidence concerns the gene FAT1 and head and neck cancer.